The future of cancer drug approval is likely to involve greater use of [precision medicine](https://www.cancer.gov), which tailors treatments to individual patients based on genetic, environmental, and lifestyle factors. Advances in biomarkers, [immunotherapy](https://www.cancer.gov), and artificial intelligence are expected to improve the efficiency and accuracy of the drug approval process, leading to more personalized and effective cancer treatments.
